Amphastar Pharmaceuticals Operating Expenses 2012-2024 | AMPH

Amphastar Pharmaceuticals operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Amphastar Pharmaceuticals Annual Operating Expenses
(Millions of US $)
2023 $447
2022 $391
2021 $368
2020 $339
2019 $322
2018 $303
2017 $241
2016 $240
2015 $258
2014 $228
2013 $212
2012 $179
2011 $152
2009 $49
Amphastar Pharmaceuticals Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $134
2024-06-30 $127
2024-03-31 $124
2023-12-31 $124
2023-09-30 $108
2023-06-30 $109
2023-03-31 $107
2022-12-31 $97
2022-09-30 $97
2022-06-30 $99
2022-03-31 $99
2021-12-31 $97
2021-09-30 $87
2021-06-30 $91
2021-03-31 $93
2020-12-31 $93
2020-09-30 $80
2020-06-30 $89
2020-03-31 $77
2019-12-31 $84
2019-09-30 $78
2019-06-30 $78
2019-03-31 $83
2018-12-31 $88
2018-09-30 $73
2018-06-30 $74
2018-03-31 $68
2017-12-31 $62
2017-09-30 $61
2017-06-30 $63
2017-03-31 $55
2016-12-31 $68
2016-09-30 $58
2016-06-30 $58
2016-03-31 $55
2015-12-31 $63
2015-09-30 $68
2015-06-30 $64
2015-03-31 $64
2014-12-31 $63
2014-09-30 $68
2014-06-30 $50
2014-03-31 $48
2013-12-31 $52
2013-09-30 $59
2013-06-30 $51
2013-03-31 $51
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.335B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Bausch Health Cos (BHC) Canada $3.439B 2.49
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00